SectorBiological Technology
Established Date--
Listing Date13/09/2017
ExchangeNASDAQ Stock Exchange
Full-time Employees32
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressPO Box 13628, 68 TW Alexander Drive , Research Triangle Park, NC 27709
Business
IntroductionFennec Pharmaceuticals Inc., originally established as a British Columbia company under the name "Sticky" Technologies, changed its name on September 3, 2014. Fennec, together with its wholly owned subsidiaries Oxyquit Corporation (" Oxide ") and Fennec Pharmaceuticals, and a Canadian company in Canada (" CBI "), collectively referred to here as the "Company", is a biopharmaceutical company with a product in development for the treatment of cancer. The Company is a biopharmaceutical company focused on the development of sodium thiosulfate (" STS ") to prevent the toxicity of platinum poisoning in pediatric cancer patients.
